Pharmacokinetics and Pharmacodynamics of Anthocyanins
| Status: | Recruiting |
|---|---|
| Conditions: | Gout |
| Therapuetic Areas: | Rheumatology |
| Healthy: | No |
| Age Range: | 18 - 65 |
| Updated: | 3/7/2019 |
| Start Date: | February 1, 2019 |
| End Date: | September 1, 2019 |
| Contact: | Naomi Schlesinger, MD |
| Email: | schlesna@rwjms.rutgers.edu |
| Phone: | 732-235-7217 |
PKPD of Anthocyanins After Oral Cherry Juice Concentrate in Gout Patients
The purpose of the study is to establish the pharmacokinetic parameters of cherry juice
concentrate and identify its potential to alter inflammatory markers in gout patients.
concentrate and identify its potential to alter inflammatory markers in gout patients.
Inclusion Criteria:
- Diagnosis of gout
Exclusion Criteria:
- Allergy to cherries or cherry products
- Any history of malignancy
- History of any pancreatic or biliary tract disease
- Significant Anemia
- History of significant renal (sCr > 1.5 mg/dL)
- Hepatic disease (liver enzymes 3 times upper limit of normal)
- Any active gastrointestinal condition
- History of large bowel resection for any reason
- Use of cherry juice concentrate or consumption of cherries within 14 days
- Personal or inherited bleeding disorders or currently on anticoagulation
- Women of childbearing age not on oral contraceptives
- Women who are pregnant or nursing
We found this trial at
1
site
Click here to add this to my saved trials
